Issue link: http://www.insightdigital.biz/i/548712
24 | I NSIGH T • A u g u s t 2 0 15 w w w . i n s i g h t o n b u s i n e s s . c o m administrative fee plus the cost of the drugs," he says. "ere are no hidden costs. We also pride ourselves on meeting enrollees' needs by giving them great customer service. When you call Navitus, you get a person — not a phone tree. It's those personal touches that matter and make a difference." Ludka, senior vice president of customer operations and chief compliance officer, can expect to get a lot more questions in the months to come as Navitus breaks ground this fall on a second building along Interstate 41 in Appleton. e company, which is headquartered in Madison but has a large presence in Appleton with more than 300 employees, has grown tremendously in the past few years as businesses, insurance companies, third-party administrators and government programs realize the need to have a company manage their prescription benefit plans. Since Navitus was formed in 2003, it has grown to serve more than 300 clients and administer prescription drug plans for more than 4.2 million people. e key to the company's growth is being able to meet clients' needs by providing great customer service while also lowering their overall drug costs, says Navitus CEO and President Terry Seligman. "We are a completely transparent company. Our clients pay us a flat We're an employer of choice for those who work in call centers. They've heard about how we're all about meeting customers' needs and that we're not trying to push them off the phones to get a higher call volume. We want to make sure our clients' needs are met on that first call." —Debbie Ludka, senior vice president of customer operations and chief compliance officer Debbie Ludka, senior vice president of customer operations and chief compliance officer for Navitus, leads the company's Appleton office. Navitus was founded in 2003 when the leaders of Appleton's Touchpoint Plan (then operated by ThedaCare) and Madison's Dean HealthPlan decided to spin off their prescription drug plans into a new company. Elixir for growth c o n t i n u e d